 |
XVIVO Perfusion
Last updated: August 02, 2024
Magnus Nilsson, CEO
Sweden | Funding: €50K (+)
Website: http://www.xvivoperfusion.com/
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
Website: http://www.xvivoperfusion.com/
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
